120 related articles for article (PubMed ID: 33125593)
21. Atomic bomb and leukemia.
Ichimaru M; Tomonaga M; Amenomori T; Matsuo T
J Radiat Res; 1991 Mar; 32 Suppl():162-7. PubMed ID: 1762101
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic and molecular changes in leukemia among atomic bomb survivors.
Kamada N; Tanaka K; Oguma N; Mabuchi K
J Radiat Res; 1991 Dec; 32 Suppl 2():257-65. PubMed ID: 1823362
[TBL] [Abstract][Full Text] [Related]
23. Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia.
Matsuo T; Tomonaga M; Bennett JM; Kuriyama K; Imanaka F; Kuramoto A; Kamada N; Ichimaru M; Finch SC; Pisciotta AV
Jpn J Clin Oncol; 1988 Jun; 18(2):91-6. PubMed ID: 2898029
[TBL] [Abstract][Full Text] [Related]
24. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
Ishimaru T; Otake M; Ischimaru M
Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
[No Abstract] [Full Text] [Related]
25. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors.
Neriishi K; Stram DO; Vaeth M; Mizuno S; Akiba S
Radiat Res; 1991 Feb; 125(2):206-13. PubMed ID: 1996379
[TBL] [Abstract][Full Text] [Related]
26. Acute myelogenous leukemia with monosomy 7 in a Hiroshima survivor 60 years after the atomic bomb.
Takahashi T; Harada S; Oki M; Yoshimoto M; Tsujisaki M; Maemori M; Sakai H
Cancer Genet Cytogenet; 2006 Oct; 170(2):182-3. PubMed ID: 17011994
[No Abstract] [Full Text] [Related]
27. A long-term cohort study of the atomic-bomb survivors.
Kodama K; Mabuchi K; Shigematsu I
J Epidemiol; 1996 Aug; 6(3 Suppl):S95-105. PubMed ID: 8800280
[TBL] [Abstract][Full Text] [Related]
28. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure.
Imaizumi M; Usa T; Tominaga T; Neriishi K; Akahoshi M; Nakashima E; Ashizawa K; Hida A; Soda M; Fujiwara S; Yamada M; Ejima E; Yokoyama N; Okubo M; Sugino K; Suzuki G; Maeda R; Nagataki S; Eguchi K
JAMA; 2006 Mar; 295(9):1011-22. PubMed ID: 16507802
[TBL] [Abstract][Full Text] [Related]
29. Did atomic bomb radiation influence the incidence of retinoblastoma in Nagasaki and Hiroshima?
Amemiya T; Takano J; Choshi K
Ophthalmic Paediatr Genet; 1993 Jun; 14(2):75-9. PubMed ID: 8233356
[TBL] [Abstract][Full Text] [Related]
30. Chronic myeloid leukemia as an immunological target.
Lim SH; Coleman S
Am J Hematol; 1997 Jan; 54(1):61-7. PubMed ID: 8980262
[TBL] [Abstract][Full Text] [Related]
31. Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide.
Bosch GJ; Joosten AM; Kessler JH; Melief CJ; Leeksma OC
Blood; 1996 Nov; 88(9):3522-7. PubMed ID: 8896419
[TBL] [Abstract][Full Text] [Related]
32. Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study.
Itakura K; Takahashi I; Nakashima E; Yanagi M; Kawasaki R; Neriishi K; Wang JJ; Wong TY; Hida A; Ohishi W; Kiuchi Y
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5401-6. PubMed ID: 26275137
[TBL] [Abstract][Full Text] [Related]
33. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
34. Leukemia: lessons from the Japanese experience.
Finch SC
Stem Cells; 1997; 15 Suppl 2():135-9. PubMed ID: 9368297
[TBL] [Abstract][Full Text] [Related]
35. [Gene rearrangement and radiation carcinogenesis].
Akiyama M
Rinsho Ketsueki; 1994 May; 35(5):454-60. PubMed ID: 8028192
[TBL] [Abstract][Full Text] [Related]
36. [Differential diagnosis of chronic myeloid leukemia and the related disorders].
Ashida T; Kanamaru A
Nihon Rinsho; 2001 Dec; 59(12):2358-62. PubMed ID: 11766339
[TBL] [Abstract][Full Text] [Related]
37. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
38. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950--30 September 1966.
Ishimaru T; Hoshino T; Ichimaru M; Okada H; Tomiyasu T
Radiat Res; 1971 Jan; 45(1):216-33. PubMed ID: 5275936
[No Abstract] [Full Text] [Related]
39. A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes.
Serody JS; Brecher ME; Dent G; Bentley SA; Frelinger JA; Shea TC
Cancer Res; 1997 Apr; 57(8):1547-53. PubMed ID: 9108458
[TBL] [Abstract][Full Text] [Related]
40. Accurate prediction of the age incidence of chronic myeloid leukemia with an improved two-mutation mathematical model.
Lecca P; Sorio C
Integr Biol (Camb); 2016 Dec; 8(12):1261-1275. PubMed ID: 27801472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
